<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="152962">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01809990</url>
  </required_header>
  <id_info>
    <org_study_id>BIPOCD1</org_study_id>
    <nct_id>NCT01809990</nct_id>
  </id_info>
  <brief_title>Internet-delivered CBT for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study</brief_title>
  <official_title>Internet-delivered Cognitive Behavior Therapy for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eva Serlachius</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stockholm County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <authority>Sweden: The National Board of Health and Welfare</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main goal of this trial is to study the feasibility and effectiveness of
      internet-delivered cognitive behavior therapy for adolescents with obsessive-compulsive
      disorder.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Children's Yale Brown Obsessive Compulsive Scale, CY-BOCS</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change from Baseline of obsessions and compulsions after 12 weeks and at 3- and 6 months after treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spence Child Anxiety Scale - Child and Parent version</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Spence Child Anxiety Scale - Child and Parent version (SCAS/P, Spence, 1998) will be used as a child and parent self-report measure of anxiety related psychopathology.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Depression Inventory</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Symptom severity of depression in the adolescent will be assessed with Child Depression Inventory (CDI, Kovacs, 1985).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strengths Difficulties Questionnaire</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Strengths Difficulties Questionnaire (SDQ, Goodman, 1997) is a widely used self- and parent-report behavioral screening questionnaire with six subscales: emotional problems, conduct problems, hyperactivity-inattention, peer problems, prosocial behavior</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Children's Obsessional Compulsive Inventory Revised</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Children's Obsessional Compulsive Inventory Revised, (CHOCI-R, Shafran et al., 2003) is a self- and parent-report measure of pediatric OCD symptom severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Obsessive-Compulsive Impact Scale - Revised</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Child Obsessive-Compulsive Impact Scale - Revised (COIS-R, Piacentini, Peris, Bergman, Chang, &amp; Jaffer, 2007) is a self- and parent-report scale of OCD symptom impact on everyday life.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient Health Questionnaire PHQ-9</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient Health Questionnaire PHQ-9 (Kroenke, Spitzer, &amp; Williams, 2001) is a brief self-report measure of depressive symptoms in adults. PHQ-9 will be used to measure parental depressive symptoms.</description>
  </other_outcome>
  <other_outcome>
    <measure>GAD-7</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>GAD-7 (Spitzer, Kroenke, Williams, &amp; LÃ¶we, 2006) is a brief self-report measure of symptoms of general anxiety in adults. GAD-7 will be used to measure symptoms of anxiety in the parents.</description>
  </other_outcome>
  <other_outcome>
    <measure>Obsessive Compulsive Inventory - Revised</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Obsessive Compulsive Inventory - Revised (OCI-R, Foa et al., 2002) is a reliable and valid 18-item self-report scale for screening of OCD in adults and will be used to measure parental OC symptoms of both parents.</description>
  </other_outcome>
  <other_outcome>
    <measure>Family Accommodation Scale, Parent-Report</measure>
    <time_frame>Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended</time_frame>
    <safety_issue>No</safety_issue>
    <description>Family Accommodation Scale, Parent-Report (FAS-PR, Flessner et al., 2009). The parent-report version of the FAS consists of 12 items focusing on accommodation behaviors of parents with a child with OCD.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>internet-delivered cognitive behavior therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be assigned to a 12 weeks internet-delivered cognitive behavior therapy program including therapist contact via an internet platform and telephone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet-delivered Cognitive Behavior Therapy</intervention_name>
    <arm_group_label>internet-delivered cognitive behavior therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a primary diagnosis of OCD as defined by DSM-IV TR

          -  a total score of above 15 on the CY-BOCS

          -  age between 12 and 17 years

          -  ability to read and write Swedish

          -  daily access to the internet

          -  a parent that is able to co-participate in the treatment

          -  Participants on psychotropic medication must have been on a stable dose for the last
             6 weeks prior to baseline assessment

          -  signed informed consent

        Exclusion Criteria:

          -  diagnosed autism spectrum disorder, psychosis or bipolar disorder

          -  suicidal ideation

          -  ongoing substance dependence

          -  subject not able to read or understand the basics of the ICBT self-help material

          -  completed CBT for OCD within last 12 months (defined as at least 5 sessions CBT
             including exposure and response prevention)

          -  ongoing psychological treatment for OCD or another anxiety disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Serlachius, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska insititute</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, Salkovskis PM. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002 Dec;14(4):485-96.</citation>
    <PMID>12501574</PMID>
  </reference>
  <reference>
    <citation>Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997 Jul;38(5):581-6.</citation>
    <PMID>9255702</PMID>
  </reference>
  <reference>
    <citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.</citation>
    <PMID>11556941</PMID>
  </reference>
  <reference>
    <citation>Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52.</citation>
    <PMID>9183141</PMID>
  </reference>
  <reference>
    <citation>Shafran R, Frampton I, Heyman I, Reynolds M, Teachman B, Rachman S. The preliminary development of a new self-report measure for OCD in young people. J Adolesc. 2003 Feb;26(1):137-42.</citation>
    <PMID>12550826</PMID>
  </reference>
  <reference>
    <citation>Spence SH. A measure of anxiety symptoms among children. Behav Res Ther. 1998 May;36(5):545-66.</citation>
    <PMID>9648330</PMID>
  </reference>
  <reference>
    <citation>Spitzer RL, Kroenke K, Williams JB, LÃ¶we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.</citation>
    <PMID>16717171</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>November 18, 2013</lastchanged_date>
  <firstreceived_date>February 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Eva Serlachius</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>cognitive behavior therapy</keyword>
  <keyword>pediatric obsessive-compulsive disorder</keyword>
  <keyword>internet-delivered cognitive behavior therapy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
